PAZALVEN Trademark

Trademark Overview

On Monday, April 8, 2019, a trademark application was filed for PAZALVEN with the United States Patent and Trademark Office. The USPTO has given the PAZALVEN trademark a serial number of 88375829. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by Johnson & Johnson. The PAZALVEN trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
pazalven

General Information

Serial Number88375829
Word MarkPAZALVEN
Filing DateMonday, April 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Translation of Words in MarkThe wording "PAZALVEN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022SOU EXTENSION 5 GRANTED
Thursday, March 24, 2022SOU EXTENSION 5 FILED
Wednesday, March 30, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 24, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 27, 2021SOU EXTENSION 4 GRANTED
Monday, September 27, 2021SOU EXTENSION 4 FILED
Monday, September 27, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 23, 2021SOU EXTENSION 3 GRANTED
Tuesday, March 23, 2021SOU EXTENSION 3 FILED
Tuesday, March 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2020SOU EXTENSION 2 GRANTED
Friday, September 18, 2020SOU EXTENSION 2 FILED
Friday, September 18, 2020SOU TEAS EXTENSION RECEIVED
Friday, March 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 25, 2020SOU EXTENSION 1 GRANTED
Wednesday, March 25, 2020SOU EXTENSION 1 FILED
Wednesday, March 25, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 1, 2019ASSIGNED TO LIE
Friday, June 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 21, 2019EXAMINER'S AMENDMENT ENTERED
Friday, June 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 21, 2019EXAMINERS AMENDMENT E-MAILED
Friday, June 21, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 18, 2019ASSIGNED TO EXAMINER
Wednesday, April 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 11, 2019NEW APPLICATION ENTERED

Related Keywords

pazalven diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory